Data as of May 24
| +0.40 / +0.85%|
The 15 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 38.00, with a high estimate of 48.00 and a low estimate of 29.00. The median estimate represents a -19.83% decrease from the last price of 47.40.
The current consensus among 21 polled investment analysts is to Hold stock in Bristol-Myers Squibb Co. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.